… of COVID-19, but the functional state of T cells in these patients is not known. Based on the
retrospective study of 522 patients with COVID-19 … 14 patients with COVID-19 and 3 controls. …

… myeloid cell dysregulation, leading to immunopathology and severe disease, and discuss
potential therapeutic strategies targeting myeloid cells as a new paradigm for COVID-19 …

… Severe COVID-19 was marked by occurrence of neutrophil … the myeloid cell compartment
associated with severe COVID-19. … dysregulated myeloid cell responses to severe COVID-19. …

… cell compartment, with increased myeloid-… and myeloid cell dysregulation in COVID-19
infection and discuss the potential of MDSCs as biomarkers and therapeutic targets in COVID-19 …

… another myeloid cell subset is significant for the poor prognosis of severe COVID-19 patients…
trajectory of myeloid cells and critical transcription factors in COVID-19 patients provides a …

… Extreme myeloid cell compartment changes during COVID-19 were also reported by a
multipronged approach characterized by an elevation in HLA-DR hi CD11c hi /HLA-DR hi CD83 …

… The six hallmarks are dysregulated type I IFN activity, hyperinflammation, … , dysregulated
myeloid response, and heterogeneous adaptive immunity to SARS-CoV-2. Dysregulation and …

… A dysregulated myeloid cell compartment is one of the most striking immunopathologic …
of myeloid cells with immunoregulatory activities in the periphery and airways of COVID-19 …

… levels of STAT3 phosphorylation in myeloid and lymphocytic cells [… was accompanied by
decreased myeloid cell activation in … pathway for the dysregulation observed in COVID-19 [18]. …

… and dysregulated immune responses involving T and myeloid cells occur in COVID-19 …
In addition, the role of CD8+ T cells present in the lung of COVID-19 patients and relevant …